🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Major advance in the fight against #TB 🚨: Today, the World Health Organization (WHO) recommended four new, shorter, and more effective treatment regimens for curing drug-resistant TB. These treatments were studied in the endTB trial, led by PIH, MSF International & IRD Global. Read more: pih.org/press/major-ad…

A huge loss for health activism in SA, a fighter to the end. Rest peacefully Vicki 💜

We co-authored this article calling for better access to long-acting antiretroviral meds for #HIV treatment & prevention. Current drugs are under the firm control of pharma corporations & unavailable or cost-prohibitive for people in much of the world.

Sign this petition calling on Gilead Sciences to make the #HIV drug #lenacapavir accessible for people in low- & middle-income countries. Right now it's sold in high-income countries for treatment at $42,000/yr! But generics could be made for just $40. ✍️ secure.avaaz.org/campaign/en/en…

New technologies are transforming health care, including for people living with HIV - including long-acting prevention and treatment medicines. These must be affordable and available as a global public good - now! sciencedirect.com/science/articl…

Liposomal amphotericin B (LAmB) is a lifesaving medicine for many infectious diseases, but people in low- & middle-income countries lack access to it. MSF's Jessica Burry, @dndi & others address the access barriers in this The Lancet Global Health article. msfaccess.org/lancet-global-…

We & CSOs call on Gavi, the Vaccine Alliance & UNICEF to ensure affordable pricing of the #mpox vaccine + support ‌Africa CDC's outbreak response coordination efforts in procuring & distributing vaccines doses - affordably, equitably & transparently. msfaccess.org/letter-csos-ca…

🚨 Must Read 🚨 MSF Access Campaign & HJI write about the groundbreaking CompComSA investigation on a key TB DRUG in 2023 (BDQ) -that led to evergreening patents AND price being dropped, benefiting not just SA. 📲 spotlightnsp.co.za/2024/08/30/com… Via Spotlight Treatment Action Group (TAG) Stop TB Partnership

Lifesaving tests can only save lives when they’re accessible! Sign the petition asking Cepheid & Danaher Corporation to drop the price of GeneXpert tests for all diseases so more lives can be saved. Your voice matters! #TimeFor5 🖊️timefor5.msfaccess.org

Why does Danaher Corporation refuse to release the GeneXpert audit they promised to make public? Is it because tests cost less than they claim? Is it because they're just dilly-dallying while 100,000 people die of TB every MONTH? Regardless, it's unacceptable. msfaccess.org/hidden-costs-g…

BIG news from India: People with drug-resistant TB can now access BPaLM i.e. more efficacious, much shorter, all-oral and has less side effects. It will also ensure better adherence and ambulatory treatment for many. Congrats to everyone who finally made this happen!